Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

\

Numinus Wellness Inc. (T:NUMI)

Business Focus: Biotechnology & Medical Research (NEC)

INK Edge Outlook

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for NUMI within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Oct 05, 2022 07:30 ET
Numinus Develops Mushroom Tea for Use in Psychedelic Research
Psilocybin-containing tea bag offers substitute for whole mushrooms and other solid therapeutics
Read full article
Oct 05, 2022 07:30 ET
Numinus Develops Mushroom Tea for Use in Psychedelic Research
Psilocybin-containing tea bag offers substitute for whole mushrooms and other solid therapeutics
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
21.89
7.58
4.54
Price to Book - most recent quarter
1.40
2.51
1.83
Price to Cash Flow per share - TTM
--
13.86
10.24
Price to Free Cash Flow per share - TTM
--
14.88
15.03
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Sep 15, 2022430,444121,683
Aug 31, 2022308,761183,737
Aug 15, 2022125,024-25,910
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Numinus Wellness Inc. is a Canada-based integrated mental wellness company that provides ketamine- and psychedelic-assisted therapies. The Company is engaged in the integrative health industries and operates through three divisions: Numinus Biosciences, Numinus Health and Mindspace Psychology Services. Numinus Bioscience provides services, including cultivation, analytical testing, product research and development, and ancillary services under its Health Canada licenses. The testing license allows the Company to test and analyze cannabis products from licensed producers, and the dealer's license allows the Company to test, possess, buy and sell methylenedioxymethamphetamine (MDMA), psilocybin, psilocin, dimethyltryptamine (DMT) and mescaline. Numinus Health and Mindspace Psychology Services operates centers located in Vancouver, British Columbia and Montreal, Quebec. The Company operates 13 wellness clinics, four clinical research facilities and a psychedelics research lab.

See business summary

 

Twitter

Search (past week) for $NUMI.CA

  • No tweets found